<DOC>
	<DOCNO>NCT02202655</DOCNO>
	<brief_summary>The purpose study investigate change lymphocyte subset chemotherapy course patient non-small cell lung cancer</brief_summary>
	<brief_title>Study Changes Lymphocyte Subsets Chemotherapy Course Patients With Non-small Cell Lung Cancer</brief_title>
	<detailed_description>patient primary non-small cell lung cancer receive first chemotherapy Beijing Chaoyang Hospital affiliate Capital Medical University collect , percentage lymphocyte subset 9 time point , , chemotherapy detect flow cytometry method.We investigate change patient ' lymphocyte subset chemotherapy course . The correlation percentage lymphocyte subset age , gender , pathological type , clinical stage , surgery , clinical efficacy assessment analyze .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Each Period Nonsmall Cell Lung Cancer , Which Was Confirmed Histopathology . patient lung cancer . Functional Status Score ( PS ) â‰§ 70 . The first time chemotherapy . A Written Informed Consent . Merging tumor . HAve autoimmune disease . AIDS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>non- small cell lung cancer ;</keyword>
	<keyword>lymphocyte subset</keyword>
</DOC>